Interaction between mevalonate pathway and retinoic acid-induced differentiation
暂无分享,去创建一个
[1] N. Gueddari,et al. Enhancement of all-trans-retinoic acid efficiency in granulocytic differentiation of HL-60 cells by incorporation into low density lipoprotein. , 1998, International Journal of Oncology.
[2] Marshall Cj,et al. Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein. , 1995 .
[3] N. Takahashi,et al. Potential applications of cytodifferentiation therapy in hematologic malignancies. , 1994, Seminars in hematology (Print).
[4] M. Lanotte,et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Allen,et al. Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells. , 1994, Leukemia research.
[6] P. Edwards,et al. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1994, The Journal of biological chemistry.
[7] J. Ericsson,et al. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. , 1994, Biochimica et biophysica acta.
[8] G. Prendergast,et al. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton , 1994, Molecular and cellular biology.
[9] P. Edwards,et al. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. , 1994, The Journal of biological chemistry.
[10] M. Favata,et al. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis. , 1993, The Journal of biological chemistry.
[11] J. Fruchart,et al. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. , 1993, Clinical chemistry.
[12] M. Andreeff,et al. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. , 1993, Cancer research.
[13] C J Marshall,et al. Protein prenylation: a mediator of protein-protein interactions. , 1993, Science.
[14] P. Casey,et al. Biochemistry of protein prenylation. , 1992, Journal of lipid research.
[15] Gregor Eichele,et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.
[16] J. Grippo,et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.
[17] T. Osborne. Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1991, The Journal of biological chemistry.
[18] R. Evans,et al. Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Gibbs. Ras C-terminal processing enzymes—New drug targets? , 1991, Cell.
[20] J. Brockes. Reading the retinoid signals , 1990, Nature.
[21] M. Gelb,et al. Prenyl proteins in eukaryotic cells: a new type of membrane anchor. , 1990, Trends in biochemical sciences.
[22] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.
[23] P. Casey,et al. p21ras is modified by a farnesyl isoprenoid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[24] W. Schafer,et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. , 1989, Science.
[25] C. Marshall,et al. All ras proteins are polyisoprenylated but only some are palmitoylated , 1989, Cell.
[26] J. R. Smith,et al. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. , 1988, The Journal of biological chemistry.
[27] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[28] T. Osborne,et al. Operator constitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element. , 1988, The Journal of biological chemistry.
[29] S. Collins,et al. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide , 1979, The Journal of experimental medicine.
[30] P. Fenaux,et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.
[31] C. Marshall,et al. Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein. , 1995, Oncogene.
[32] C. Farnsworth,et al. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. , 1994, Annual review of cell biology.
[33] C. Der,et al. The ras/cholesterol connection: implications for ras oncogenicity. , 1992, Critical reviews in oncogenesis.
[34] J. Brockes. Developmental biology. Reading the retinoid signals. , 1990, Nature.